Last reviewed · How we verify
Haemostasis tests
At a glance
| Generic name | Haemostasis tests |
|---|---|
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Goal-Directed Hemostatic Resuscitation Trial in ACLF Induced Coagulopathy (NA)
- Biological and Clinical Relevance of Quantra Viscoelastic Hemostatic Assay in Hemorrhagic Cardiac Surgery
- Study of Hemostasis in Patients With Congenital Disorder of Glycosylation
- Outcome Following Use of Different Concentrations of NaOCl as Wound Lavage and Hemostatic Agent in Partial Pulpotomy (NA)
- Effect of Graphene Oxide on Vital and Non-Vital Primary Teeth Compared to the Conventional Techniques (NA)
- External Multicenter Validation of the APTTO Model for Prolonged APTT Using Clot Waveform Analysis
- Cost Effectiveness in Alveolar Bone Grafting in Patients With Cleft Lip and Palate (PHASE4)
- Discomfort Following Oral Biopsy Comparing Laser and Punch Biopsy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Haemostasis tests CI brief — competitive landscape report
- Haemostasis tests updates RSS · CI watch RSS
- Assistance Publique - Hôpitaux de Paris portfolio CI